Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Oct 17;12(20):e031399.
doi: 10.1161/JAHA.123.031399. Epub 2023 Oct 13.

Randomized Controlled Trial of Moderate- and High-Intensity Exercise Training in Patients With Hypertrophic Cardiomyopathy: Effects on Fitness and Cardiovascular Response to Exercise

Affiliations
Randomized Controlled Trial

Randomized Controlled Trial of Moderate- and High-Intensity Exercise Training in Patients With Hypertrophic Cardiomyopathy: Effects on Fitness and Cardiovascular Response to Exercise

James P MacNamara et al. J Am Heart Assoc. .

Abstract

Background Moderate intensity exercise training (MIT) is safe and effective for patients with hypertrophic cardiomyopathy, yet the efficacy of high intensity training (HIT) remains unknown. This study aimed to compare the efficacy of HIT compared with MIT in patients with hypertrophic cardiomyopathy. Methods and Results Patients with hypertrophic cardiomyopathy were randomized to either 5 months of MIT, or 1 month of MIT followed by 4 months of progressive HIT. Peak oxygen uptake (V˙O2; Douglas bags), cardiac output (acetylene rebreathing), and arteriovenous oxygen difference (Fick equation) were measured before and after training. Left ventricular outflow gradient and volumes were measured by echocardiography. Fifteen patients completed training (MIT, n=8, age 52±7 years; HIT, n=7, age 42±8 years). Both HIT and MIT improved peak V˙O2 by 1.3 mL/kg per min (P=0.009). HIT (+1.5 mL/kg per min) had a slightly greater effect than MIT (+1.1 mL/kg per min) but with no statistical difference (group×exercise P=0.628). A greater augmentation of arteriovenous oxygen difference occurred with exercise (Δ1.6 mL/100 mL P=0.005). HIT increased left ventricular end-diastolic volume (+17 mL, group×exercise P=0.015) compared with MIT. No serious arrhythmias or adverse cardiac events occurred. Conclusions This randomized trial of exercise training in patients with hypertrophic cardiomyopathy demonstrated that both HIT and MIT improved fitness without clear superiority of either. Although the study was underpowered for safety outcomes, no serious adverse events occurred. Exercise training resulted in salutary peripheral and cardiac adaptations. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT03335332.

Keywords: arrhythmias; cardiac output; exercise; fitness; high intensity; hypertrophic cardiomyopathy; training.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Overview of study design.
Schematic of study design (left) and Consolidated Standards of Reporting Trials diagram (right) showing flow of participants through the study. EF indicates ejection fraction; HCM, hypertrophic cardiomyopathy; HF, heart failure; HIT, high intensity training; LVOT, left ventricular outflow tract; MIT, moderate intensity training; and NYHA, New York Heart Association Class.
Figure 2
Figure 2. Primary change in fitness after exercise training.
Group response in peak V̇O2 to exercise training, independent of intensity, is shown as absolute V̇O2 (A) and indexed to body mass (C). B and D, The response in peak V̇O2 to exercise training by intensity. Lines represent individual participant changes and bars mean value of the group. Exercise effect and group×exercise interaction of a repeated measures mixed model are shown. HIT indicates high intensity training; MIT, moderate intensity training; and V̇O2, oxygen uptake.
Figure 3
Figure 3. Cardiac and peripheral responses to exercise.
Group changes in peak cardiac output (A), augmentation of cardiac output during peak exercise (B), peak arteriovenous oxygen difference, (C), and augmentation of arteriovenous oxygen difference during peak exercise (D) are shown, independent of exercise intensity. Exercise effect of repeat measures mixed model are shown.
Figure 4
Figure 4. Summary of study results.
Summary of study design and results are shown. HIT indicates high intensity training; ICD, implantable cardiac defibrillator; ILR, implantable loop recorder; LV, left ventricular; MIT, moderate intensity training; and VO2, oxygen uptake.

References

    1. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;142:e533–e557. doi: 10.1161/CIR.0000000000000938 - DOI - PubMed
    1. Braunwald E, Lambrew CT, Rockoff SD, Ross J Jr, Morrow AG. Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation. 1964;30(suppl 4):3–119. doi: 10.1161/01.cir.29.5s4.iv-3 - DOI - PubMed
    1. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA. 1999;281:650–655. doi: 10.1001/jama.281.7.650 - DOI - PubMed
    1. Maron BJ, Rowin EJ, Casey SA, Garberich RF, Maron MS. What do patients with hypertrophic cardiomyopathy die from? Am J Cardiol. 2016;117:434–435. doi: 10.1016/j.amjcard.2015.11.013 - DOI - PubMed
    1. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA III, Cooper LT Jr, Link MS, Maron MS; American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology . Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e273–e280. doi: 10.1161/CIR.0000000000000239 - DOI - PubMed

Publication types

Associated data

LinkOut - more resources